SPX and polycystic ovary syndrome: In primary human GC, we observed that SPX at 1, 10, and 100 nM decreased HSD3B transcript levels in GC of the normal weight, obese, and PCOS obese groups and at doses of 10 and 100 nM in the PCOS normal weight group (Figure 4C, P < 0.05).